Tucson Symposium 2019

AGENDA

 Subject to change
Tuesday, April 9, 2019
 
 8:00 am Tucson Symposium Welcome and Opening Remarks 
 8:15 am Tom Grogan Honorary Keynote Lecture
 Tumor and Host Factors Regulating Immunotherapy Efficacy
 Thomas Gajewski, MD, PhD (confirmed)
University of Chicago
Chicago, Illinois
Session 1
New Combinations for Personalizing Immunotherapy and Targeting Resistance
 8:55 am Session Introduction
 9:00 am Biomarkers for Personalized Immunotherapy
 David Rimm, MD, PhD (confirmed)
Yale University
New Haven, Connecticut
 9:20 am
Using Science to Guide Rational Combinations for Immunotherapy
Roy Herbst, MD, PhD (confirmed)
Yale Cancer Center
New Haven, Connecticut
 9:40 am Spatial Interactions in the Tumor Microenvironment
 Janis Taube, MD,MSc (confirmed)
John Hopkins University of Medicine
Baltimore, Maryland
10:00 am
Panel Discussion | Q&A | Session Close
  
10:30 am Break
 
Session 2
Digital Pathology 

10:45 am Session Introduction
10:50 am
Digital Pathology: Future Proofing Cancer Services
 Bethany Williams, MBBS, BSc (confirmed)
Leeds Teaching Hospital NHS Trust, University of Leeds
Leeds, UK
11:10 am Artificial Intelligence for Immuno-oncology Pathology:
From Discovery to AI-powered Companion Diagnostics

Andrew Beck, MD, PhD (confirmed)
PathAI
Cambridge, Massachusetts
11:30 am Opportunities and Challenges Adopting Digital Pathology for Primary Diagnosis Workflow



Anil Parwani, MD. PhD, MBA (confirmed) The Ohio State University
Columbus, Ohio
11:50 am Panel Discussion | Q&A | Session Close
  
12:20 pm Lunch
  
 1:30 pm Poster Session
 
Session 3 
New Frontiers in Colorectal Cancer

 2:45 pm Session Introduction
 2:50 pm
Targeted Therapies in Colorectal Cancer
 Scott Kopetz, MD, PhD (confirmed)
MDAnderson Cancer Center Houston, Texas
 3:10 pm
Q&A
 3:20 pm Immunotherapy for MSI Metastatic Colorectal Cancer: Going Beyond MSI for Immunotherapy in Metastatic Colorectal Cancer
Thierry Andre, MD (confirmed)
Hôpital Saint-Antoine
Paris, France
 3:40 pm Pathological Features of Tumors Displaying Microsatellite Instability and State-of-the-Art for their Screening
Magali Svrcek, MD, PhD (invited)
Hôpital Saint-Antoine
Paris, France
 4:00 pm
Implications of MSI and BRAF Status for Treatment of Non-metastatic Colon Cancer: Immune Markers and Immunotherapy
 Frank Sinicrope, MD (confirmed)
Mayo Clinic
Rochester, Minnesota
 4:20 pm Panel Discussion | Q&A | Session Close
 4:50 pm Close of day one 
  
 6:30 pm Dinner program - El Conquistador Tucson
Heathcare and the Fourth Industrial Revolution
Robert C. Robbins, MD
President of The University of Arizona
Former President and CEO,
Texas Medical Center in Houston, Texas
Wednesday, April 10, 2019
 8:00 am Welcome
 Ray Tubbs Memorial Keynote Lecture
 8:10 am Immunogenic Cancer Cell Death – A Strategy for Sensitizing to Immune Checkpoint Blockade

Guido Kroemer, MD, PhD (confirmed)
University of Paris Descartes
Paris, France
Session 4
Tumor Heterogeneity and Cancer Evolution 
 8:50 am Session Introduction
 8:55 am Chromosomal Instability and Genome Plasticity in Cancer Evolution, Immune Evasion and Metastasis
Charles Swanton, MD, PhD (confirmed)
The Francis Crick Institute

London, United Kingdom

 9:15 am Bioinformatic Dissection of Cancer Genomic Heterogeneity

Nicholas McGranahan, PhD (confirmed)
University College of London
London, United Kingdom
 9:35 am
Searching for Biomarkers of Response and Resistance to Checkpoint Inhibition
 Samra Turajlic, MD, PhD (confirmed) The Francis Crick Institute London, UK
 9:55 am Panel Discussion | Q&A | Session Close
  
10:25 am Break
 
Session 5
Hot Topics in Surgical Pathology
10:40 am Session Introduction
10:45 am
Pathology in the Post TGCA World
Jorge Reis-Filho, MD, PhD (confirmed) Memorial Sloan Kettering Cancer Center New York, New York
11:05 amMachine Learning in Pathology with Use Cases in Genomics and Digital Pathology
Long Le. MD, PhD (confirmed)
Massachusetts General Hospital
Boston, Massachusetts
11:25 am Panel Discussion | Q&A | Session Close
  
11:45 am Lunch
 
Session 6
Translational Medicine
 1:00 pm Session Introduction
 1:05 pm
Gut Microbiome: Cancer, Immunity and Cancer Immunotherapy
 Jennifer Wargo, MD, MMSc (confirmed)
MDAnderson Cancer Center
Houston, Texas

 1:25 pmQ & A 
 1:35 pm
Unravelling the Role of the Microbiome in Colorectal Cancer
 Phil Quirke, MD, PhD (confirmed)
Leeds Institute of Cancer and Pathology
Leeds, United Kingdom
 1:55 pm
Q&A
 2:05 pm
Session Close
Session 7
Immunology

 2:10 pm
Session Introduction
 2:15 pm
Panomic Spatial Profiling of Tumor Microenviorments to Decipher Immune Response
 Richard Terry ​(confirmed) Readcoor Cambridge, Massachusetts
 2:35 pm All the Single Cells, All the Single Cells...
Multi-omics Single-cell Technology to Map Clonal Evolution Topographies


Dan Landau, MD, PhD (confirmed)
Weill Cornell Medicine/New York Genome Center
New York, New York

  
 2:55 pm Break
  
 3:10 pm
Immunomodulation and Vaccines for Tumor Prevention
 Olivera Finn, PhD (confirmed)
University of Pittsburgh Pittsburgh, Pennsylvania
 3:30 pm
Partnership for Accelerating Cancer Therapies (PACT): A Public-Private Partnership to Standardize and Harmonize
Biomarkers to Advance New Immunotherapy Treatments
 Stacey Adam, PhD ​(confirmed)
Foundation for the National Institutes of Health
Bethesda, Maryland
 3:50 pm Panel Discussion | Q&A | Session Close
 4:30 pm Tucson Symposium 2019 Closing
 4:45 pm Symposium Adjourns

Daruka Mahadevan, MD, PhD
The University of Arizona Cancer Center
United States (Arizona)
Daruka Mahadevan, MD, PhD
The University of Arizona Cancer Center
United States (Arizona)

The Gut Microbiota to PD-1 Response/Resistance in Lung and Renal Cell Cancers

Cancer Microbiota and Host Response

Charles Swanton, MD, PhD (tentative)
The Francis Crick Institute
United Kingdom (London)

Keith Kerr
Aberdeen University Medical School
Scotland, UK
Keith Kerr
Aberdeen University Medical School
Scotland, UK
Keith Kerr
Aberdeen University Medical School
Scotland, UK
Christian Jobin, PhD
University of Florida College of Medicine
United States (Florida) 
Christian Jobin, PhD
University of Florida College of Medicine
United States (Florida) 
Christian Jobin, PhD
University of Florida College of Medicine
United States (Florida) 

Thierry Andre, MD (invited)
Hôpital Saint-Antoine
Paris, France
Andrew Beck, MD, PhD (invited)
PathAI
Cambridge, Massachusetts
Andrew Beck, MD, PhD (invited)
PathAI
Cambridge, Massachusetts

Bioinformatic Dissection of Cancer Genomic Heterogeneity

Top